Clinical Research Directory
Browse clinical research sites, groups, and studies.
Migraine Attack Treatment Response Molecular and Clinical BiOmarkers (MAMBO) Phase I
Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Summary
The goal of this observational study is to identify differential traits in spontaneous migraine attacks that can help us predict the response to treatment with sumatriptan. Participants will be asked to register the headache characteristics before and after taking sumatriptan and whether the treatment was effective or not during four migraine attacks.
Official title: Migraine Attack Treatment Response Molecular and Clinical BiOmarkers (The MAMBO Study) Phase I
Key Details
Gender
All
Age Range
18 Years - 45 Years
Study Type
OBSERVATIONAL
Enrollment
108
Start Date
2024-01-25
Completion Date
2024-12
Last Updated
2024-10-28
Healthy Volunteers
No
Conditions
Interventions
Sumatriptan
Register the response to treatment and headache characteristics.
Locations (1)
Hospital Universitari Vall d'Hebron
Barcelona, Spain